199 related articles for article (PubMed ID: 36473990)
1. Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Wu H; Tang LX; Wang XM; Li LP; Chen XK; He YJ; Yang DZ; Shi Y; Shou JL; Zhang ZS; Wang L; Lu BJ; An SM; Zeng CY; Wang WE
Acta Pharmacol Sin; 2023 Jun; 44(6):1149-1160. PubMed ID: 36473990
[TBL] [Abstract][Full Text] [Related]
2. A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy.
Jiang J; Lan C; Li L; Yang D; Xia X; Liao Q; Fu W; Chen X; An S; Wang WE; Zeng C
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3459-3467. PubMed ID: 30076960
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction.
Yang D; Fu W; Li L; Xia X; Liao Q; Yue R; Chen H; Chen X; An S; Zeng C; Wang WE
Clin Sci (Lond); 2017 Dec; 131(24):2919-2932. PubMed ID: 29162747
[TBL] [Abstract][Full Text] [Related]
4. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertension.
Li S; Shi Y; Yuan S; Ruan J; Pan H; Ma M; Huang G; Ji Q; Zhong Y; Jiang T
Biomed Pharmacother; 2024 Jan; 170():115987. PubMed ID: 38056241
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.
Kanashiro-Takeuchi RM; Takeuchi LM; Dulce RA; Kazmierczak K; Balkan W; Cai R; Sha W; Schally AV; Hare JM
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H739-H750. PubMed ID: 36897749
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.
Marunouchi T; Matsumura K; Fuji E; Iwamoto A; Tanonaka K
Pharmacology; 2024; 109(1):43-51. PubMed ID: 38016432
[TBL] [Abstract][Full Text] [Related]
8. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
Dulce RA; Kanashiro-Takeuchi RM; Takeuchi LM; Salerno AG; Wanschel ACBA; Kulandavelu S; Balkan W; Zuttion MSSR; Cai R; Schally AV; Hare JM
Cardiovasc Res; 2023 Feb; 118(18):3586-3601. PubMed ID: 35704032
[TBL] [Abstract][Full Text] [Related]
9. Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways.
Dawuti A; Sun S; Wang R; Gong D; Liu R; Kong D; Yuan T; Zhou J; Lu Y; Wang S; Du G; Fang L
Biomed Pharmacother; 2023 Dec; 168():115837. PubMed ID: 37931518
[TBL] [Abstract][Full Text] [Related]
10. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
Schwarzl M; Hamdani N; Seiler S; Alogna A; Manninger M; Reilly S; Zirngast B; Kirsch A; Steendijk P; Verderber J; Zweiker D; Eller P; Höfler G; Schauer S; Eller K; Maechler H; Pieske BM; Linke WA; Casadei B; Post H
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1407-18. PubMed ID: 26342070
[TBL] [Abstract][Full Text] [Related]
11. Activation of Peroxisome Proliferator-activated Receptor γ Prevents Development of Heart Failure With Preserved Ejection Fraction; Inhibition of Wnt-β-catenin Signaling as a Possible Mechanism.
Kamimura D; Uchino K; Ishigami T; Hall ME; Umemura S
J Cardiovasc Pharmacol; 2016 Aug; 68(2):155-61. PubMed ID: 27046338
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
13. Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway.
Zhao Z; Liu H; Li Y; Tian J; Deng S
Med Sci Monit; 2020 Apr; 26():e923025. PubMed ID: 32279067
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
[TBL] [Abstract][Full Text] [Related]
16. microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2.
Dong S; Ma W; Hao B; Hu F; Yan L; Yan X; Wang Y; Chen Z; Wang Z
Int J Clin Exp Pathol; 2014; 7(2):565-74. PubMed ID: 24551276
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
18. TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction.
Zuo GF; Wang LG; Huang L; Ren YF; Ge Z; Hu ZY; Zhang JJ; Chen SL
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166979. PubMed ID: 38065272
[TBL] [Abstract][Full Text] [Related]
19. CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction.
Zhang N; Ma Q; You Y; Xia X; Xie C; Huang Y; Wang Z; Ye F; Yu Z; Xie X
Int J Biol Sci; 2022; 18(3):1271-1287. PubMed ID: 35173552
[No Abstract] [Full Text] [Related]
20. WNT/β-Catenin Signaling Promotes TGF-β-Mediated Activation of Human Cardiac Fibroblasts by Enhancing IL-11 Production.
Działo E; Czepiel M; Tkacz K; Siedlar M; Kania G; Błyszczuk P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
